LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Long non-coding RNA PCGEM1 is upregulated in cervical cancer (CC) and promotes tumor growth. Inhibiting PCGEM1 reduces CC cell proliferation, migration, and invasion, suggesting it as a therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Cervical cancer (CC) involves dysregulated long non-coding RNAs (lncRNAs).
- The role of lncRNA prostate cancer gene expression marker 1 (PCGEM1) in CC remains uninvestigated, despite its known oncogenic roles in other cancers.
- Understanding PCGEM1's function in CC is crucial for developing targeted therapies.
Purpose Of The Study
- To investigate the expression and functional role of PCGEM1 in cervical cancer.
- To elucidate the molecular mechanisms underlying PCGEM1's involvement in CC progression.
- To identify potential therapeutic targets for CC based on PCGEM1 signaling.
Main Methods
- Real-time PCR to quantify PCGEM1 expression in CC cells.
- RNA interference (shRNA) to suppress PCGEM1 expression.
- Cell proliferation assays (CCK-8, EdU, colony formation), migration and invasion assays (wound healing, Transwell).
- Western blot and immunofluorescence for epithelial-to-mesenchymal transition (EMT) markers.
- Bioinformatics analysis, luciferase reporter assay, and miRNA manipulation to confirm molecular interactions.
Main Results
- PCGEM1 expression was significantly upregulated in CC cells.
- PCGEM1 suppression inhibited CC cell proliferation, migration, and invasion.
- PCGEM1 promoted EMT by downregulating E-cadherin and upregulating N-cadherin.
- PCGEM1 acts as a competing endogenous RNA (ceRNA) for miR-642a-5p, modulating KIF5B expression.
- Restoring miR-642a-5p partially reversed the effects of PCGEM1 suppression.
Conclusions
- PCGEM1 plays a crucial oncogenic role in cervical cancer progression.
- The PCGEM1/miR-642a-5p/KIF5B axis is a key signaling pathway in CC.
- Targeting the PCGEM1/miR-642a-5p/KIF5B axis represents a potential therapeutic strategy for cervical cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...